ELLANSÉ™ M

Product Description

ELLANSÉ™ M is a dermal filler that combines immediate volumization with long-term collagen stimulation for comprehensive facial rejuvenation. This advanced cosmetic filler utilizes polycaprolactone microspheres suspended in a carboxymethylcellulose gel carrier to deliver both instant correction and sustained aesthetic enhancement. ELLANSÉ™ M represents a significant advancement in dermal filler technology, offering medical professionals a reliable solution for patients seeking durable facial volume restoration.

ELLANSÉ™ M Dosage and Administration

ELLANSÉ™ M should be administered by qualified medical professionals experienced in dermal injection techniques. The recommended injection depth is mid-to-deep dermal layer, with dosage varying according to the specific treatment area and desired correction level. Before injection, the product should be brought to room temperature and thoroughly mixed using gentle rolling motions. Treatment sessions typically require 1-2 ml per area, though individual patients may require volume adjustments based on their specific anatomical considerations and aesthetic goals.

Ingredient Information

The primary active component consists of polycaprolactone microspheres, a biodegradable polymer that has been extensively used in medical applications for decades. The carboxymethylcellulose gel carrier facilitates immediate volume correction and serves as the delivery medium for the microspheres. Unlike hyaluronic fillers, ELLANSÉ™ does not rely on water binding for volume maintenance, instead promoting the body’s natural collagen production mechanisms through controlled degradation.

Storage Instructions

ELLANSÉ™ M requires storage at temperatures between 15°C and 25°C in a dry environment protected from direct sunlight. The products should remain in their original packaging until use to maintain sterility and product integrity. Freezing must be avoided, as it may compromise the microsphere structure and the stability of the gel carrier.

ELLANSÉ™ M Contraindications

ELLANSÉ™ M is contraindicated in patients with known hypersensitivity to any formulation components. Active skin infections or inflammatory conditions at the proposed injection site preclude treatment until the condition resolves.

Specific contraindications include:

• Known hypersensitivity to polycaprolactone microspheres or carboxymethylcellulose

• Active skin infections or inflammatory conditions at injection sites

• Pregnancy and breastfeeding are due to insufficient safety data

• Autoimmune disorders require careful evaluation

• Severe bleeding disorders or active anticoagulation therapy

ELLANSÉ™ M Precautions and Warnings

Medical professionals must ensure proper injection technique to avoid intravascular injection, which may result in serious complications, including tissue necrosis. Patients should be advised to avoid extreme temperatures, excessive sun exposure, and strenuous physical activity for 24 to 48 hours after treatment. Healthcare providers should maintain detailed records of injection sites, volumes administered, and lot numbers for products used.

ELLANSÉ™ M Manufacturer and Regulatory Information

Sinclair Pharma manufactures ELLANSÉ™ M under strict quality control standards and regulatory compliance. The products are marked with the CE marking for distribution in the European Union and comply with international standards for medical device safety and efficacy. Healthcare professionals seeking to buy ELLANSÉ™ M should ensure procurement from authorized distributors to guarantee product authenticity. When seeking to order ELLANSÉ™ M 2×1 ml or buy ELLANSÉ™ M 2×1 ml formulations, verification of supplier credentials ensures compliance with medical device regulations and patient safety standards.